Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Salinosporamide A is a natural proteasome inhibitor.1 It is a β-lactone-γ-lactam that irreversibly inhibits all three protease activities within the proteasome (IC50s = 3.5, 28, and 430 nM for β5 (chymotrypsin), β2 (macropain), and β1 (C5) subunits, respectively), both in vitro and in vivo.2,3 Salinosporamide A has potential applications in cancer therapy, particularly in combination with other chemotherapeutics.1,2
WARNING This product is not for human or veterinary use.
1. Proteasome inhibitors -
2. A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from bortezomib. Cancer Cell 8(5), 407-419 (2005).
3. Molecular mechanisms of acquired proteasome inhibitor resistance. J. Med. Chem. 55(23), 10317-10327 (2012).